Skip to main content
Carimatech has unveiled the ZENESIS bio-3D printer featuring a unique Direct Glass Printing technology that maintains over 90 percent cell viability.
Product
1 min read

Carimatech has unveiled the ZENESIS bio-3D printer featuring a unique Direct Glass Printing technology that maintains over 90 percent cell viability.

Carimatech
Carimatech

Hardware

Originally reported by AMEnews

Carimatech has unveiled the ZENESIS bio-3D printer featuring a unique Direct Glass Printing technology that maintains over 90 percent cell viability. This system delivers a 144-fold increase in productivity compared to manual methods, outputting more than 300 samples per minute for high-throughput drug screening. Simultaneously, the company has launched a government-backed project to develop smart mass production systems for industrial ceramic 3D printing. These advancements signal a critical...

Explore CarimatechRead Original

How This Connects

6 related events
  1. Same pattern

    Auxilium Biotechnologies is partnering with Starlab Space to deploy the AMP-1 bioprinting platform for scalable medical manufacturing in low Earth orbit.

  2. Same pattern

    PrintBio has joined a federal consortium led by WFIRM to receive up to 24.8 million USD from ARPA-H for bioprinting vascularized kidney tissue.

  3. Same pattern

    Carnegie Mellon University secured a 28.5 million dollar ARPA-H award for the LIVE project, developing 3D-printed human liver patches.

  4. Same pattern

    Aspect Biosystems has expanded its partnership with Novo Nordisk to develop bioprinted islet therapies for Type 1 diabetes.

  5. Company story

    Carimatech has launched its project to industrialize ceramic 3D printing through a smart mass production framework.

  6. Same pattern

    Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant.

  7. This article

    Carimatech has unveiled the ZENESIS bio-3D printer featuring a unique Direct Glass Printing technology that maintains over 90 percent cell viability.